Transcutaneous Electrical Acupoint Stimulation on Gastrointestinal Function After Cesarean Section (TEAS)

August 7, 2017 updated by: wangqiang, Xijing Hospital

Effect of Perioperative Transcutaneous Electrical Acupoint Stimulation on Gastrointestinal Function After Cesarean Section

To determine whether treating by transcutaneous electrical acupoint stimulation (TEAS) during perioperative could alleviate the postoperative gastrointestinal complications after cesarean section under combined spinal epidural anesthesia compared with control and non-acupoint group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Acupuncture is a traditional Chinese medical technique that involves the insertion of needles at acupoints to treat diseases.Clinical evidence supports the efficacy of acupuncture treatment in many applications. Some previous studies reported that stimulation at some acupoint exerted good effects on the digestive system.Compared with acupuncture, transcutaneous electric acupoint stimulation(TEAS) is a non-invasive technique that has similar effects to acupuncture.We hypothesize that TEAS before anesthesia and during surgery would decrease the morbidity and mortality of postoperative complications in 30 days after Cesarean section.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. ASA physical status 1or2, scheduled for elective cesarean section under combined spinal epidural anesthesia
  2. Gestational age ≥38 weeks
  3. Provide written informed consent

Exclusion Criteria:

  1. ASA status≥Ⅲ
  2. Patients undergoing surgery within 12 h of admission to hospital
  3. Patients with fetal anomaly,medical or obstetric complications such as Diabetes mellitus、Hypertension、Obesity(BMW≥35)
  4. Patients suffered from drug addiction or impaired mental state
  5. Patients who have a history of gastrointestinal surgery or chronic gastrointestinal disease.
  6. Patients with contraindications to the use of electro-acupuncture, such as skin damage or infection at the acupoints
  7. Patients with experience of transcutaneous electrical stimulation treatment
  8. Participate in the other clinical trial 3 months before the enrollment
  9. Not suitable to participate in this experiment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TEAS group
TEAS are performed by a specific investigator on the specially acupoint.
According to ancient Chinese medical books, acupoints SP6 and ST36 are chosen and identified.The patients in TEAS group received electrical stimulation with the 'disperse-dense' waves. Non-acupoint is located 2cm interior to the ST36 and SP6.For group TEAS and Sham, TEAS will be administered 30 minutes prior to surgery and continued until the end of the surgery.Control patients will receive the same treatment without electrical stimulation.
Other Names:
  • Transcutaneous electrical acupoint stimulation
Sham Comparator: Sham group
TEAS are performed by a specific investigator on the non-acupoint.
According to ancient Chinese medical books, acupoints SP6 and ST36 are chosen and identified.The patients in TEAS group received electrical stimulation with the 'disperse-dense' waves. Non-acupoint is located 2cm interior to the ST36 and SP6.For group TEAS and Sham, TEAS will be administered 30 minutes prior to surgery and continued until the end of the surgery.Control patients will receive the same treatment without electrical stimulation.
Other Names:
  • Transcutaneous electrical acupoint stimulation
Placebo Comparator: Control group
Only place cutted electrodes but do not give any electrical stimulation.
According to ancient Chinese medical books, acupoints SP6 and ST36 are chosen and identified.The patients in TEAS group received electrical stimulation with the 'disperse-dense' waves. Non-acupoint is located 2cm interior to the ST36 and SP6.For group TEAS and Sham, TEAS will be administered 30 minutes prior to surgery and continued until the end of the surgery.Control patients will receive the same treatment without electrical stimulation.
Other Names:
  • Transcutaneous electrical acupoint stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to the presence of bowel sound, time to the first passage of flatus, time to the first passage of stool , time to the start of regular diet
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 5 days
This is a composite outcome to estimate the gastrointestinal motility function
Participants will be followed for the duration of hospital stay, an expected average of 5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electrogastrogram
Time Frame: The first and second days after surgery
The first and second days after surgery
Rate of nausea, vomiting, cramping abdominal pain, abdominal distension
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 5 days
This is a composite outcome to estimate the complication of digestive system
Participants will be followed for the duration of hospital stay, an expected average of 5 days
length of postoperative hospital stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 5 days
Participants will be followed for the duration of hospital stay, an expected average of 5 days
Quality of life during 30 days after surgery
Time Frame: One month
This is a scale to evaluate the quality of life after surgery
One month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Qiang Wang, Xijing Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 26, 2016

Study Registration Dates

First Submitted

April 2, 2015

First Submitted That Met QC Criteria

April 14, 2015

First Posted (Estimate)

April 15, 2015

Study Record Updates

Last Update Posted (Actual)

August 9, 2017

Last Update Submitted That Met QC Criteria

August 7, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Xijing H (XijingH)
  • mazuike (Other Identifier: Xijing Hospital)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section

Clinical Trials on TEAS

3
Subscribe